Participated · Equity · May 2026

Infinigence AI develops full-stack, AI-native infrastructure technologies and products focused on the requirements of large models and AGI-related workloads. The company was founded in May 2023 and is led by co-founder and CEO Xia Lixue, with co-founders including Tsinghua professor Wang Yu and Chief Scientist Dai Guohao. It is positioned as a multi-heterogeneous technology provider aiming to expand large-scale computing power for the Token economy and to build infrastructure with autonomous evolution capabilities. The company has raised over CNY2.2 billion to date, including the latest raise of more than CNY700 million. Management says the new funds will be used to consolidate its technology stack, scale compute capacity, accelerate productivity shifts, and deliver infrastructure solutions across industry scenarios. The company is described in reporting as a leading AI-native infrastructure firm in China by cumulative funding.

Participated · Equity · Mar 2026

Robotera builds full-stack humanoid robots combining AI "brain" systems, motion control, dexterous hands and humanoid hardware, and positions itself toward logistics and industrial deployments. The company reports beginning deliveries of several thousand units in Q2 2026 and claims deployments in over ten logistics centers across China with partners including SF Group and China Post. Robotera states it has achieved up to 85% of human efficiency in some logistics contexts operating 24/7 and cites a claimed 300% growth rate (no baseline published). Its investor and partner base spans logistics, automotive and consumer electronics players such as SF Group, Geely, Renault (cited as a partner), Alibaba, Samsung, Lenovo and Haier, which the company and articles present as potential channels for further deployments. Financially, the company has raised nearly ¥2.5 billion RMB (~$350M) in total capital following the recent financing, which the company says supports scaling production and broader commercial rollouts. The articles note competition from Western and Chinese robotics firms but highlight Robotera’s operational logistics focus and industrial partnerships as key differentiators.

Participated · Series C · Nov 2021

金仕生物 is a platform company concentrating on innovative devices for structural heart disease, with product lines that include surgical bioprosthetic valves, annuloplasty rings, bio‑patches, TAVR and interventional mitral and tricuspid devices. The company originated from surgical valve products and has accumulated extensive valve processing and manufacturing know‑how. Its surgical product line (annuloplasty rings and surgical bioprosthetic valves) is already on the market; the bio‑patch is expected to complete registration this year. The company’s third‑generation transcatheter aortic valve replacement (TAVR) system is nearing completion of clinical trial enrollment and may become the first approved third‑gen valve. Management plans to use new funding to accelerate R&D and rollout of mitral and tricuspid interventional products, advance third‑gen TAVR registration, and scale mass production of surgical biovalves and bio‑patches. The firm positions itself to capture domestic import‑substitution opportunities in a market currently dominated by foreign incumbents and to benefit from rising TAVR adoption. Founded in 2012, Jinshi Bio focuses on cardiac surgical products and micro‑invasive interventional valves built around bioprosthetic valve core technologies. Its product portfolio includes next‑generation bioprosthetic heart valves, micro‑invasive interventional valves, annuloplasty rings and biological patches. The company owns proprietary technologies such as a 3D double‑saddle annuloplasty ring design, anti‑calcification treatments, dry‑film preservation and leaflet thinning techniques, which the article describes as filling domestic gaps and being internationally advanced. Its annuloplasty ring has received national special approval for innovative medical devices and will be launched soon, while its bioprosthetic valves are nearing completion of clinical trials. Jinshi positions its products as high‑end import substitutes and aims to capture China’s high‑end valve market by leveraging its innovation and first‑mover advantages. The company recently completed a Series B financing, strengthening its financial position for clinical and commercial advancement.

Led · Series A · Aug 2018

Pico is a Chinese VR manufacturer founded in 2015 and led by CEO Henry Zhou. The company develops all-in-one VR headsets, launching the Pico Neo DK in 2016 based on Qualcomm’s Snapdragon 820 and later the Goblin series. It introduced the 6‑DoF Pico Neo at the end of 2017. Pico is actively deploying B2B solutions across education, real estate, insurance, automotive and medical sectors, partnering with brands such as China Life, Mengniu, Toyota and Volkswagen. The company holds 435 domestic authorized patents and 192 authorized (49 accepted) overseas patents and employs more than 300 people. Pico maintains offices in Beijing, Qingdao, San Francisco, Tokyo, Barcelona and other regions.

Led · Series A · Aug 2018

Pico Interactive develops VR and AR hardware and enterprise solutions for consumer and business users. Led by CEO Zhou Hongwei, the company offers headsets and interactive CGI solutions and launched four new headsets in 2020. Pico operates across the United States, Europe, China and Japan. It closed a $37.4M (€31.4M) Series B+ round and has raised $67.23M (€56.48M) in B and B+ funding to date. The company plans to use the proceeds to grow its B2C presence in Asia, expand B2B partnerships in Western markets, and accelerate new product development. Pico Interactive focuses on self-contained standalone virtual reality headsets rather than PC- or console-tethered systems. The company announced a new China-bound headset called the Pico G2, an updated version of the Pico Goblin built on Qualcomm’s 835 chipset. Pico’s hardware runs on HTC’s Vive Wave VR platform. The startup was founded in 2015 and this fundraise is its first outside financing since founding. Management says it plans to release its own augmented reality hardware in 2019. The company raised capital amid a market where competitors have aggressively cut prices, compressing margins for hardware players.